Literature DB >> 16688458

Lower urinary tract symptoms, urinary incontinence, sexual function and quality of life after radical prostatectomy and external beam radiation therapy: real life experience in Austria.

Anton Ponholzer1, Clemens Brössner, Gerhard Struhal, Martin Marszalek, Stephan Madersbacher.   

Abstract

The objective of this study was to assess lower urinary tract symptoms (LUTS), urinary incontinence (UI), erectile dysfunction (ED) and quality of life after radical prostatectomy (RPE) and external beam radiation therapy (EBRT) in a "real-life" setting. A consecutive series of patients undergoing routine follow-up after RPE and EBRT at 28 Austrian institutions were analyzed. Men who received adjuvant therapy were excluded. All patients completed a questionnaire on (a) LUTS and UI, (b) sexual function and (c) quality of life. A total of 364 patients following RPE and 82 after EBRT entered this study and were compared in a matched pair analysis (1:1) based on age, PSA at diagnosis and follow-up (RPE: n=82; EBRT: n=82). Mean time-interval between treatment and current investigation was 4.6 years for RPE and 4.4 years for EBRT (n.s.). UI was reported by 41.3% after RPE and 18.8% after EBRT (P=0.001). Urgency was more frequent after EBRT, this difference, however, did not reach statistical significance. Moderate to severe ED (IIEF-5, <17) was present in 80.0% after RPE and in 80.8% after EBRT (n.s.). On a ten-point scale, RPE-patients rated their quality of life higher (7.3) than after EBRT (6.7) (P=0.01). In this "real-life" setting, RPE and EBRT had significant, yet divergent effects on LUTS, UI and sexual function. The respective numbers were substantially higher than those usually reported by physician-directed studies and centers of excellence.

Entities:  

Mesh:

Year:  2006        PMID: 16688458     DOI: 10.1007/s00345-006-0075-1

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  23 in total

1.  Quality of life in T1-3N0 prostate cancer patients treated with radiation therapy with minimum 10-year follow-up.

Authors:  P A Johnstone; C Gray; C R Powell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-03-01       Impact factor: 7.038

2.  Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy.

Authors:  C L Shrader-Bogen; J L Kjellberg; C P McPherson; C L Murray
Journal:  Cancer       Date:  1997-05-15       Impact factor: 6.860

3.  Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.

Authors:  J B Madalinska; M L Essink-Bot; H J de Koning; W J Kirkels; P J van der Maas; F H Schröder
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

4.  Quality of life after treatment for localized prostate cancer: differences based on treatment modality.

Authors:  J W Davis; D A Kuban; D F Lynch; P F Schellhammer
Journal:  J Urol       Date:  2001-09       Impact factor: 7.450

5.  Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas.

Authors:  F J Fowler; M J Barry; G Lu-Yao; J H Wasson; L Bin
Journal:  J Clin Oncol       Date:  1996-08       Impact factor: 44.544

6.  The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing.

Authors:  S Jackson; J Donovan; S Brookes; S Eckford; L Swithinbank; P Abrams
Journal:  Br J Urol       Date:  1996-06

7.  Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor.

Authors:  M S Litwin; S C Flanders; D J Pasta; M L Stoddard; D P Lubeck; J M Henning
Journal:  Urology       Date:  1999-09       Impact factor: 2.649

8.  Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer.

Authors:  K A McCammon; P Kolm; B Main; P F Schellhammer
Journal:  Urology       Date:  1999-09       Impact factor: 2.649

9.  Cross-sectional study of nocturia in both sexes: analysis of a voluntary health screening project.

Authors:  G Schatzl; C Temml; J Schmidbauer; B Dolezal; G Haidinger; S Madersbacher
Journal:  Urology       Date:  2000-07       Impact factor: 2.649

10.  Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy.

Authors:  W J Catalona; J W Basler
Journal:  J Urol       Date:  1993-09       Impact factor: 7.450

View more
  7 in total

1.  Trends in prostate cancer survival in Spain: results from population-based cancer registries.

Authors:  Rafael Marcos-Gragera; Diego Salmerón; Isabel Izarzugaza; Eva Ardanaz; Bernat-Carles Serdà; Nerea Larrañaga; Erkuden San Román; Carmen Navarro; María-Dolores Chirlaque
Journal:  Clin Transl Oncol       Date:  2012-06       Impact factor: 3.405

2.  Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: evidentiary base.

Authors:  Joseph L Chin; John Srigley; Linda A Mayhew; R Bryan Rumble; Claire Crossley; Amber Hunter; Neil Fleshner; Bish Bora; Robin McLeod; Sheila McNair; Bernard Langer; Andrew Evans
Journal:  Can Urol Assoc J       Date:  2010-02       Impact factor: 1.862

3.  Urinary incontinency after radical prostatectomy and effects of 1 month pre-operative biofeedback training.

Authors:  Hossein Abdollahi Veshnavei
Journal:  Am J Clin Exp Urol       Date:  2021-12-15

4.  Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment.

Authors:  Michael Pinkawa; Karin Fischedick; Bernd Gagel; Marc D Piroth; Branka Asadpour; Jens Klotz; Holger Borchers; Gerhard Jakse; Michael J Eble
Journal:  BMC Cancer       Date:  2009-08-24       Impact factor: 4.430

5.  Radical prostatectomies in Austria, 1997-2004.

Authors:  Gerald Haidinger; Stephan Madersbacher; Georg Schatzl; Christian Vutuc
Journal:  BMC Res Notes       Date:  2008-07-21

6.  Supportive care needs of men living with prostate cancer in England: a survey.

Authors:  E Ream; A Quennell; L Fincham; S Faithfull; V Khoo; J Wilson-Barnett; A Richardson
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

7.  High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center.

Authors:  Bengt Johansson; Johan Staby Olsén; Leif Karlsson; Erik Lundin; Bo Lennernäs
Journal:  J Contemp Brachytherapy       Date:  2021-05-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.